David Silberman

Insider Reports History

Location
Jerusalem, Israel
Signature
/s/ David Silberman
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Silberman:

Company Role Class Num Shares Value Price $ Report Date Ownership
ORAMED PHARMACEUTICALS INC. Chief Financial Officer Common Stock 366,500 $809,965 $2.21 04 Jan 2024 Direct

Insider Reports Filed by David Silberman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ORMP ORAMED PHARMACEUTICALS INC. 04 Jan 2024 1 $0 4 Chief Financial Officer 08 Jan 2024, 16:39
ORMP ORAMED PHARMACEUTICALS INC. 26 May 2023 1 $0 4 Chief Financial Officer 31 May 2023, 17:10
ORMP ORAMED PHARMACEUTICALS INC. 17 Apr 2023 1 $0 4 Chief Financial Officer 20 Apr 2023, 06:00
ORMP ORAMED PHARMACEUTICALS INC. 28 Jul 2022 1 $0 4 Chief Financial Officer 01 Aug 2022, 20:00
ORMP ORAMED PHARMACEUTICALS INC. 03 Jan 2022 2 $0 4 Chief Financial Officer 05 Jan 2022, 19:32
ORMP ORAMED PHARMACEUTICALS INC. 01 Sep 2021 2 $0 4 Chief Financial Officer 02 Sep 2021, 16:48
ORMP ORAMED PHARMACEUTICALS INC. 05 Jul 2021 0 $0 3 Chief Financial Officer 08 Jul 2021, 16:30